Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder / Arthur Robin Williams en The American Journal of Psychiatry, Año 2020 - Vol. 177 - No. 2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 2 (Febrero) . - pp. 117-124 Título : Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder Tipo de documento: texto impreso Autores: Arthur Robin Williams, Autor ; Hillary Samples, Autor ; Stephen Crystal, Autor Fecha de publicación: 2020 Artículo en la página: pp. 117-124 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Trastorno por consumo de opioides, Buprenorfina, Tratamiento asistido por medicamentos, Medicamentos para el trastorno por consumo de opioides, Sobredosis, Medidas de calidad Resumen: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum. Link: ./index.php?lvl=notice_display&id=24742 [artículo] Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder [texto impreso] / Arthur Robin Williams, Autor ; Hillary Samples, Autor ; Stephen Crystal, Autor . - 2020 . - pp. 117-124. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 2 (Febrero) . - pp. 117-124 Etiquetas: Trastorno por consumo de opioides, Buprenorfina, Tratamiento asistido por medicamentos, Medicamentos para el trastorno por consumo de opioides, Sobredosis, Medidas de calidad Resumen: Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum. Link: ./index.php?lvl=notice_display&id=24742

---

1 (1 - 1 / 1) Por página: 25 50 100 200